AKT1 and neoplasm: In another recent study, suppression of the PI3K/Akt pathway using the specific PI3K inhibitor LY294002 showed that PI3K/Akt pathway inactivation affects BMP9-mediated tumor-suppressive effects in gastric cancer cells [26].